A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
Clinical trial NCT04971226 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04971226
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-06
- Primary completion
- 2023-11-28
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.